Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Work In Process (2023 - 2024)

Harmony Biosciences Holdings' Work In Process history spans 2 years, with the latest figure at $3.5 million for Q4 2024.

  • For Q4 2024, Work In Process rose 72.72% year-over-year to $3.5 million; the TTM value through Dec 2024 reached $3.5 million, up 72.72%, while the annual FY2024 figure was $3.5 million, 72.72% up from the prior year.
  • Work In Process for Q4 2024 was $3.5 million at Harmony Biosciences Holdings, up from $2.5 million in the prior quarter.
  • Across five years, Work In Process topped out at $3.5 million in Q4 2024 and bottomed at $1.7 million in Q2 2024.